SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medtronic plc - MDT

Wednesday, July 19, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, July 18, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medtronic plc ("Medtronic"

or the "Company") (NYSE: MDT). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Medtronic and certain of its

officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here to join a class action]

On July 17, 2017, Medtronic disclosed that a June 2017 computer crash that shut down Medtronic's global ordering, fulfillment, and manufacturing systems would impact the Company's quarterly sales.

On this news, Medtronic's share price fell $2.51, or 2.8%, to close at $86.06 on July 17, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT: Robert S. Willoughby Pomerantz LLP rswilloughby@pomlaw.com

 

View original content:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-medtronic-plc--mdt-300490202.html

SOURCE Pomerantz LLP



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook